https://www.selleckchem.com/pr....oducts/FK-506-(Tacro
CY STAGE 2. 3 TECHNICAL EFFICACY STAGE 2. Alouatta spp. are highly susceptible to yellow fever (YF) infection and develop an often fatal disease. The threat posed by an outbreak started in 2016 leads us to investigate vaccination as a potential tool in preventing YF in non-human primates (NHP). Susceptible howler monkeys were immunized with three different concentrations of the human Brazilian commercial YF17DD vaccine. Post-vaccination viremia/RNAemia, immunogenicity, and safety were characterized. The vaccine did not produ
Like
Comment
Share
